Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ZR75B | HR+ | Luminal | Gefitinib | EGFR | ErbB | 0.0107 | uM | 9997.049 | 1.0084 | 1.0146 | 1.1423 | |
ZR75B | HR+ | Luminal | Gefitinib | EGFR | ErbB | 6.67 | uM | 9997.049 | 0.9793 | 0.9637 | 1.1423 | |
ZR75B | HR+ | Luminal | Gefitinib | EGFR | ErbB | 33.3 | uM | 9997.049 | 0.8815 | 0.7909 | 1.1423 | |
ZR75B | HR+ | Luminal | Geldanamycin | HSP90 | HSP90 | 0.032 | uM | 9997.049 | 0.8474 | 0.7301 | 1.1423 | |
ZR75B | HR+ | Luminal | Geldanamycin | HSP90 | HSP90 | 0.0064 | uM | 9997.049 | 1.0223 | 1.0390 | 1.1423 | |
ZR75B | HR+ | Luminal | Topotecan | TOP1 | TOP | 4.37 | uM | 9997.121 | 0.5022 | 0.0766 | 1.1121 | |
ZR75B | HR+ | Luminal | CPT-11 | TOP1 | TOP | 0.000218 | uM | 9997.121 | 1.0909 | 1.1628 | 1.1121 | |
ZR75B | HR+ | Luminal | Topotecan | TOP1 | TOP | 0.175 | uM | 9997.121 | 0.6053 | 0.2734 | 1.1121 | |
ZR75B | HR+ | Luminal | Doxorubicin | TOP2 | TOP | 0.0294 | uM | 9997.121 | 0.9840 | 0.9712 | 1.1121 | |
ZR75B | HR+ | Luminal | Topotecan | TOP1 | TOP | 109 | uM | 9997.121 | 0.0557 | -0.8510 | 1.1121 | |
ZR75B | HR+ | Luminal | CPT-11 | TOP1 | TOP | 0.0273 | uM | 9997.121 | 1.0333 | 1.0597 | 1.1121 | |
ZR75B | HR+ | Luminal | Topotecan | TOP1 | TOP | 0.0349 | uM | 9997.121 | 0.7056 | 0.4617 | 1.1121 | |
ZR75B | HR+ | Luminal | Doxorubicin | TOP2 | TOP | 0.147 | uM | 9997.121 | 0.8778 | 0.7788 | 1.1121 | |
ZR75B | HR+ | Luminal | Topotecan | TOP1 | TOP | 21.8 | uM | 9997.121 | 0.1423 | -0.6536 | 1.1121 | |
ZR75B | HR+ | Luminal | CPT-11 | TOP1 | TOP | 0.136 | uM | 9997.121 | 0.9923 | 0.9861 | 1.1121 | |
ZR75B | HR+ | Luminal | Topotecan | TOP1 | TOP | 0.00699 | uM | 9997.121 | 0.8975 | 0.8147 | 1.1121 | |
ZR75B | HR+ | Luminal | Doxorubicin | TOP2 | TOP | 0.736 | uM | 9997.121 | 0.5905 | 0.2453 | 1.1121 | |
ZR75B | HR+ | Luminal | Topotecan | TOP1 | TOP | 0.00028 | uM | 9997.121 | 1.1261 | 1.2254 | 1.1121 | |
ZR75B | HR+ | Luminal | CPT-11 | TOP1 | TOP | 0.682 | uM | 9997.121 | 0.8470 | 0.7225 | 1.1121 | |
ZR75B | HR+ | Luminal | Topotecan | TOP1 | TOP | 0.0014 | uM | 9997.121 | 1.0034 | 1.0061 | 1.1121 | |
ZR75B | HR+ | Luminal | Doxorubicin | TOP2 | TOP | 92 | uM | 9997.121 | 0.0272 | -0.9219 | 1.1121 | |
ZR75B | HR+ | Luminal | Topotecan | TOP1 | TOP | 0.874 | uM | 9997.121 | 0.6055 | 0.2737 | 1.1121 | |
ZR75B | HR+ | Luminal | CPT-11 | TOP1 | TOP | 3.41 | uM | 9997.121 | 0.6801 | 0.4140 | 1.1121 | |
ZR75B | HR+ | Luminal | Doxorubicin | TOP2 | TOP | 18.4 | uM | 9997.121 | 0.2081 | -0.5124 | 1.1121 | |
ZR75B | HR+ | Luminal | CPT-11 | TOP1 | TOP | 17.1 | uM | 9997.121 | 0.6110 | 0.2842 | 1.1121 |